Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Jun 18, 2024 8:37pm
122 Views
Post# 36095181

ONC chat site, let’s try to chat about Onc…

ONC chat site, let’s try to chat about Onc…Just a housekeeping item.
Top left corner of screen is a " new post" button.
How about, some ONC discussion?
I certainly appreciate not much new from Onc, however the political points, best left for s political form.
Recal my message today? I mentioned the pattern, being end of day support.
As/ my thesis , agsin today on both Nas ( reasonable volume) & the TSX....end of day support.
Certainly not an excitable SP growth. Just enough to indicate support.
Could be shorts covering on the dips?
Could be totally random? ...Too many days in a sequence to validate that.
Regarding the NAS today volume over 300,00 shares traded. Higher than listed average & much higher than recent days.
Could be quiet institutional buying?
For those who missed my original discussion @ 2:17, posted.
i mentioned to watch today for end of day support.
background, last time I saw almost exact patterns , was two weeks before the A.N. Deal.
Considering the upcoming FDA phase 3 meeting results, MBc details. Roche Gobblet, cohurt #5, first patient enrolment, All expected this quarter. aka before the end of this month....any of which is needed as part of negotiations for partership or buyout.
The trading S.P. At these levels is not important ( to me), As specifically the $$ value. I could care less.
im in until they get a parter or buyout.
HOWEVER , patterns interest me.
Tomorrow could easy prove me wrong.
fun to watch.
regardless of any discussion for or against, imho there is clear evidence of price support, end of day.
Let's see what happens tomorrow?








<< Previous
Bullboard Posts
Next >>